The Patent Finder
US

Multicyclic Amino Acid Derivatives and Methods of Their Use

US 7,723,345 In force
OverviewFamilyAssignmentsSources & methods
Collateral for a security interest recorded Apr 4, 2023 (Antares Capital LP).

Term ends Dec 12, 2026 · High confidence

Filed Dec 12, 2006 as application 11/638,677 · Granted May 25, 2010
Base term, 20 years from filing
Today
20 years from filing
2006 2026
Clock starts
Dec 12, 2006
Term ends
Dec 12, 2026
Granted
May 25, 2010
base term fee events Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 7,553,840, to Dec 12, 2026. The term already ends on or before that date, so the cap shortened nothing.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Dec 12, 2006, when this application, 11/638,677, was filedDec 12, 2026High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 7,553,840)resolves to Dec 12, 2026, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderDec 12, 2026High confidence

This family

US 7,723,345this patent
Dec 2026
Dec 2026
US 8,063,057In force
Dec 2026
Dec 2026
US 8,629,156In force
Dec 2026
Dec 2026
Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Apr 4, 2007
Reel 19110, frame 938
Devasagayaraj, Arokiasamy; Jin, Haihong; Liu, Qingyun; Marinelli, Brett; Samala, Lakshama; Shi, Zhi-cai; Tunoori, Ashok; Wang, Ying; Wu, Wenxue; Zhang, ChengminLexicon Genetics IncorporatedAssignment of Assignor's Interest
Sep 7, 2007
Reel 19799, frame 460
Zhang, HaimingLexicon Genetics IncorporatedAssignment of Assignor's Interest
Oct 19, 2009
Reel 23379, frame 949
Lexicon Genetics IncorporatedLexicon Pharmaceuticals, Inc.Change of Name
Dec 20, 2017
Reel 44958, frame 377
Lexicon Pharmaceuticals, Inc.Biopharma Credit PLCSecurity Interest
Sep 9, 2020
Reel 53721, frame 37
Tersera Therapeutics LLCNewstone Capital Partners, LLCSecurity Interest
Sep 14, 2020
Reel 53767, frame 445
Biopharma Credit PLCLexicon Pharmaceuticals, Inc.Release of Security Interest
Sep 14, 2020
Reel 53763, frame 754
Lexicon Pharmaceuticals, Inc.Tersera Therapeutics LLCAssignment of Assignor's Interest
Sep 30, 2020
Reel 53940, frame 1
Tersera Therapeutics LLCMidcap Financial Trust, As AgentSecurity Interest
Apr 4, 2023
Reel 63215, frame 724
Tersera Therapeutics LLCAntares Capital LP, as AgentSecurity Interest
Apr 4, 2023
Reel 63221, frame 546
Newstone Capital Partners, LLCTersera Therapeutics LLC; JDP Therapeutics LLCRelease of Security Interest
Apr 4, 2023
Reel 63253, frame 942
Midcap Financial Trust, As AgentTersera Therapeutics LLCRelease of Security Interest
Apr 4, 2023
reel/frame not recorded
Newstone Capital Partners, LLCTersera Therapeutics LLCRelease of Security Interest
Apr 4, 2023
reel/frame not recorded
Newstone Capital Partners, LLCJDP Therapeutics LLCRelease of Security Interest
Apr 5, 2023
Reel 63227, frame 852
Tersera Therapeutics LLCNewstone Capital Partners, LLCSecurity Interest
Jan 7, 2025
Reel 69835, frame 704
Newstone Capital Partners, LLCTersera Therapeutics LLCRelease of Intellectual Property Security Agreement Recorded at R/F 63227/0852
Apr 15, 2026
Reel 75420, frame 453
Midcap Financial TrustTersera Therapeutics LLC,Release of Intellectual Property Security Agreements at R/F 41939/0487, 46591/0544 and 53940/0001

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited